Benzinga's Top Upgrades By: Benzinga via Benzinga April 13, 2015 at 09:08 AM EDT Analysts at Goldman Sachs upgraded Clovis Oncology, Inc. (NASDAQ: CLVS) from Neutral to Buy. The price target for Clovis Oncology ... Read More >> Related Stocks: AbbVie Christopher & Banks Corp Clovis Oncology Inc Diana Shipping Inc Freeport-McMoRan Habit Rest Marathon Oil Netflix St. Jude Medical UnitedHealth Group